The Lancet Oncology: July 13, 2012

FromThe Lancet Oncology in conversation with

Start listening View podcast show

The Lancet Oncology: July 13, 2012

FromThe Lancet Oncology in conversation with

ratings:

Length:

10 minutes

Released:

Jul 13, 2012

Format:

Podcast episode

Description

Discussion of the oral MEK inhibitor trametinib in cancer treatment. .Continue this conversation on social!Follow us today at...https://twitter.com/thelancet & https://Twitter.com/TheLancetOncolhttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Released:

Jul 13, 2012

Format:

Podcast episode

Titles in the series (100)

Editors of The Lancet Oncology and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.

Skip carousel

The Lancet Oncology: March 05, 2009 by The Lancet Oncology in conversation with
13 min listen
The Lancet Oncology: March 30, 2009 by The Lancet Oncology in conversation with
6 min listen
The Lancet Oncology: April 30, 2008 by The Lancet Oncology in conversation with
13 min listen
The Lancet Oncology: March 26, 2008 by The Lancet Oncology in conversation with
12 min listen
The Lancet Oncology: November 29, 2010 by The Lancet Oncology in conversation with
8 min listen
The Lancet Oncology: October 01, 2008 by The Lancet Oncology in conversation with
17 min listen
The Lancet Oncology: January 30, 2012 by The Lancet Oncology in conversation with
9 min listen
The Lancet Oncology: December 01, 2009 by The Lancet Oncology in conversation with
8 min listen
The Lancet Oncology: December 23, 2008 by The Lancet Oncology in conversation with
13 min listen
The Lancet Oncology: July 29, 2009 by The Lancet Oncology in conversation with
6 min listen
The Lancet Oncology: February 25, 2008 by The Lancet Oncology in conversation with
13 min listen
The Lancet Oncology: August 26, 2008 by The Lancet Oncology in conversation with
9 min listen
The Lancet Oncology: October 28, 2008 by The Lancet Oncology in conversation with
5 min listen
The Lancet Oncology: August 27, 2009 by The Lancet Oncology in conversation with
13 min listen
The Lancet Oncology: June 30, 2008 by The Lancet Oncology in conversation with
9 min listen
The Lancet Oncology: May 28, 2009 by The Lancet Oncology in conversation with
11 min listen
The Lancet Oncology: April 29, 2010 by The Lancet Oncology in conversation with
12 min listen
The Lancet Oncology: September 28, 2009 by The Lancet Oncology in conversation with
5 min listen
The Lancet Oncology: January 30, 2009 by The Lancet Oncology in conversation with
6 min listen
The Lancet Oncology: March 01, 2010 by The Lancet Oncology in conversation with
5 min listen
The Lancet Oncology: June 09, 2008 by The Lancet Oncology in conversation with
14 min listen
The Lancet Oncology: November 26, 2008 by The Lancet Oncology in conversation with
10 min listen
The Lancet Oncology: January 06, 2010 by The Lancet Oncology in conversation with
16 min listen
The Lancet Oncology: November 14, 2012 by The Lancet Oncology in conversation with
8 min listen
The Lancet Oncology: April 29, 2009 by The Lancet Oncology in conversation with
10 min listen
The Lancet Oncology: February 01, 2010 by The Lancet Oncology in conversation with
7 min listen
The Lancet Oncology: August 11, 2008 by The Lancet Oncology in conversation with
12 min listen
The Lancet Oncology: January 31, 2011 by The Lancet Oncology in conversation with
5 min listen
The Lancet Oncology: August 02, 2010 by The Lancet Oncology in conversation with
8 min listen
The Lancet Oncology: October 29, 2009 by The Lancet Oncology in conversation with
30 min listen

More Episodes from The Lancet Oncology in conversation with

Skip carousel

James Shultz, Ana Patricia Ortiz, and Leticia Nogueira on cancer and compounding disasters in the Caribbean by The Lancet Oncology in conversation with
35 min listen
Bernardo Goulart on correlations of endpoints in lung cancer immunotherapy trials by The Lancet Oncology in conversation with
11 min listen
Maria Kyrgiou on innovations in gynaecological cancers and global disparities by The Lancet Oncology in conversation with
26 min listen
Georgios Lyratzopoulos on the use of chemotherapy and radiotherapy in patients with eight common cancers by The Lancet Oncology in conversation with
35 min listen
Mike Sathekge on radioligand therapy of metastatic castration-resistant prostate cancer by The Lancet Oncology in conversation with
16 min listen
Shankar Shiva on stereotactic body radiotherapy for primary renal cell carcinoma by The Lancet Oncology in conversation with
14 min listen
Neerja Bhatla on a new quadrivalent HPV vaccine by The Lancet Oncology in conversation with
12 min listen
Chandra Are on the Lancet Oncology Commission on Global Cancer Surgery by The Lancet Oncology in conversation with
44 min listen
Philipp Karschnia on tissue sampling and processing during resection of diffuse intracranial glioma by The Lancet Oncology in conversation with
17 min listen
Wanda Cui on measuring ovarian toxicity by The Lancet Oncology in conversation with
11 min listen
Ticiana Leal on Tumour Treating Fields by The Lancet Oncology in conversation with
9 min listen
Xuesong Han on cancer diagnosis during the COVID-19 pandemic in the USA by The Lancet Oncology in conversation with
13 min listen
Carlos Fernández de Larrea and Damian Green on BCMA CAR T cells in multiple myeloma by The Lancet Oncology in conversation with
34 min listen
Madeline Pe on the SISAQOL initiative by The Lancet Oncology in conversation with
14 min listen
Kadia Petricca and Joyce Kambugu on access to essential cancer medicines for children by The Lancet Oncology in conversation with
29 min listen
Mark Lythgoe on UK oncology drug approval after Brexit by The Lancet Oncology in conversation with
14 min listen
Janet Brown on the phase 2/3 STAR trial by The Lancet Oncology in conversation with
21 min listen
Valerie Speirs on biomarkers in male breast cancer by The Lancet Oncology in conversation with
18 min listen
Sameer Bakhshi on sex disparities in childhood cancer in India by The Lancet Oncology in conversation with
23 min listen
Shankar Siva on radiotherapy for primary renal cell carcinoma by The Lancet Oncology in conversation with
9 min listen
Mark Lawler and Richard Sullivan on the European Groundshot by The Lancet Oncology in conversation with
23 min listen
Samar Alhomoud on challenges for cancer control in the Gulf region by The Lancet Oncology in conversation with
11 min listen
Inge Marie Svane on mRNA vaccines for cancer treatment by The Lancet Oncology in conversation with
8 min listen
Eline Giraud and Elise Smolders on QT interval prolongation potential of anticancer by The Lancet Oncology in conversation with
12 min listen
Ignace Vergote and Maria Kyrgiou on gynaecological cancers by The Lancet Oncology in conversation with
11 min listen
David J Pinato on SARS-CoV-2 omicron outcomes among patients with cancer by The Lancet Oncology in conversation with
5 min listen
Wilfred Ngwa, Beatrice Wiafe-Addai, and David Kerr on cancer in sub-Saharan Africa by The Lancet Oncology in conversation with
31 min listen
Georgios Lyratzopoulos on emergency presentation by The Lancet Oncology in conversation with
14 min listen
Lisa Iezzoni on disabilities and cancer, and Jordan Marchak on mental health problems in young cancer survivors by The Lancet Oncology in conversation with
13 min listen
Rosie Bradley on early-stage breast cancer treatment by The Lancet Oncology in conversation with
5 min listen

Related podcast episodes

Skip carousel

The Lancet Oncology: July 29, 2011 by The Lancet Oncology in conversation with
11 min listen
The Lancet Oncology: February 01, 2010 by The Lancet Oncology in conversation with
7 min listen
The Lancet Oncology: February 10, 2012 by The Lancet Oncology in conversation with
11 min listen
The Lancet Oncology: January 30, 2012 by The Lancet Oncology in conversation with
9 min listen
The Lancet Oncology: March 01, 2010 by The Lancet Oncology in conversation with
5 min listen
The Lancet Oncology: April 29, 2010 by The Lancet Oncology in conversation with
12 min listen
The Lancet Oncology: February 22, 2012 by The Lancet Oncology in conversation with
7 min listen
The Lancet Oncology: October 28, 2011 by The Lancet Oncology in conversation with
12 min listen
EANO and palliative care: The Lancet Oncology: June 2, 2017 by The Lancet Oncology in conversation with
9 min listen
Antibody-drug conjugates for cancer therapy: The Lancet Oncology: June 01, 2016 by The Lancet Oncology in conversation with
9 min listen
The Lancet Oncology: March 29, 2010 by The Lancet Oncology in conversation with
7 min listen
The Lancet Oncology: November 29, 2010 by The Lancet Oncology in conversation with
8 min listen
Cancer survivorship in the USA: The Lancet Oncology: 30 December by The Lancet Oncology in conversation with
11 min listen
The Lancet Oncology: October 14, 2013 by The Lancet Oncology in conversation with
9 min listen
The Lancet Oncology: November 14, 2012 by The Lancet Oncology in conversation with
8 min listen
The Lancet Oncology: December 30, 2010 by The Lancet Oncology in conversation with
10 min listen
The Lancet Oncology: June 06, 2012 by The Lancet Oncology in conversation with
10 min listen
The Lancet Oncology: August 23, 2012 by The Lancet Oncology in conversation with
4 min listen
The Lancet Oncology: March 02, 2015 by The Lancet Oncology in conversation with
14 min listen
The Lancet Oncology: April 29, 2011 by The Lancet Oncology in conversation with
9 min listen
The Lancet Oncology: September 17, 2014 by The Lancet Oncology in conversation with
6 min listen
Renal surveillance: The Lancet Oncology: August 30, 2016 by The Lancet Oncology in conversation with
10 min listen
The Lancet Oncology: January 14, 2014 by The Lancet Oncology in conversation with
8 min listen
The Lancet Oncology: July 07, 2014 by The Lancet Oncology in conversation with
10 min listen
The Lancet Oncology: November 24, 2014 by The Lancet Oncology in conversation with
15 min listen
Metastatic breast cancer: The Lancet Oncology: Sept 10, 2015 by The Lancet Oncology in conversation with
9 min listen
The Lancet Oncology: August 26, 2011 by The Lancet Oncology in conversation with
10 min listen
Indel derived tumour-specific neoantigens: The Lancet Oncology: Aug 2017 by The Lancet Oncology in conversation with
8 min listen
The Lancet Oncology: October 30, 2012 by The Lancet Oncology in conversation with
13 min listen
Anne Chang on the burden of chronic respiratory diseases in Indigenous people by The Lancet Respiratory Medicine in conversation with
10 min listen

Discover this podcast and so much more

The Lancet Oncology: July 13, 2012

The Lancet Oncology: July 13, 2012

Description

Titles in the series (100)

More Episodes from The Lancet Oncology in conversation with

Related podcast episodes